These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12137411)

  • 1. Irampanel Boehringer Ingelheim.
    Feigin V
    Curr Opin Investig Drugs; 2002 Jun; 3(6):908-10. PubMed ID: 12137411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIII-890-CL. Boehringer Ingelheim.
    Meythaler J
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1733-5. PubMed ID: 12528308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIBR-1048 Boehringer Ingelheim.
    Mungall D
    Curr Opin Investig Drugs; 2002 Jun; 3(6):905-7. PubMed ID: 12137410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alicaforsen. Isis Pharmaceuticals.
    Gewirtz AT; Sitaraman S
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1401-6. PubMed ID: 11890355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NS1209/SPD 502, A Novel Selective AMPA Antagonist for Stroke, Neuropathic Pain or Epilepsy? Drug Development Lessons Learned.
    Keppel Hesselink JM
    Drug Dev Res; 2017 Mar; 78(2):75-80. PubMed ID: 28195646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY-293558. Eli Lilly & Co.
    Gilron I
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1273-8. PubMed ID: 11717815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update of neuroprotectants in clinical development for acute stroke.
    Lutsep H; Clark W
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1732-6. PubMed ID: 11892936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ONO-6818 Cortech/Ono.
    Trifilieff A
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1161-4. PubMed ID: 12211408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP-10 (AVANT Immunotherapeutics).
    Rioux P
    Curr Opin Investig Drugs; 2001 Mar; 2(3):364-71. PubMed ID: 11575706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-0139 (Shionogi).
    Wu-Wong JR
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1051-6. PubMed ID: 12186266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended therapeutic time window after focal cerebral ischemia by non-competitive inhibition of AMPA receptors.
    Elger B; Gieseler M; Schmuecker O; Schumann I; Seltz A; Huth A
    Brain Res; 2006 Apr; 1085(1):189-94. PubMed ID: 16580649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive AMPA receptor antagonists.
    Catarzi D; Colotta V; Varano F
    Med Res Rev; 2007 Mar; 27(2):239-78. PubMed ID: 16892196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPA receptors in epilepsy and as targets for antiepileptic drugs.
    Rogawski MA; Donevan SD
    Adv Neurol; 1999; 79():947-63. PubMed ID: 10514878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.
    Weiser T; Brenner M; Palluk R; Bechtel WD; Ceci A; Brambilla A; Ensinger HA; Sagrada A; Wienrich M
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1343-9. PubMed ID: 10336525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repinotan Bayer.
    Lutsep HL
    Curr Opin Investig Drugs; 2002 Jun; 3(6):924-7. PubMed ID: 12137415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy.
    Russo E; Citraro R; De Fazio S; Marra R; Gitto R; Chimirri A; De Sarro G; Di Paola ED
    Epilepsy Behav; 2008 Aug; 13(2):295-9. PubMed ID: 18514580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,3-benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects.
    Szénási G; Vegh M; Szabo G; Kertesz S; Kapus G; Albert M; Greff Z; Ling I; Barkoczy J; Simig G; Spedding M; Harsing LG
    Neurochem Int; 2008 Jan; 52(1-2):166-83. PubMed ID: 17707550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
    Langer M; Brandt C; Zellinger C; Löscher W
    Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
    Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
    Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.